IL-17 axis targeting shows substantial efficacy but faces cost and delivery hurdles
IL-17 blockers show promise for autoimmune diseases
This systematic review examines IL-17 axis targeting with monoclonal antibodies and small-molecule inhibitors across psoriasis, lupus, perio…
New review finds IL-17-targeting drugs work well for psoriasis and other conditions, but cost and side effects remain hurdles.
Chemokine networks regulate triple-negative breast cancer tumor microenvironment but clinical translation remains limited
Chemokine Targets Show Promise in Lab but Face Clinical Hurdles
This systematic review examines the role of chemokine networks and targeted interventions in the triple-negative breast cancer immune microe…
New research highlights the role of chemokine networks in breast cancer, showing strong results in labs despite challenges in current clinic…
Review summarizes therapeutic strategies targeting cGAS-STING-macrophage axis for renal fibrosis and chronic kidney disease
New Kidney Damage Pathway Discovered—And Scientists Are Already Blocking It
This narrative review examines emerging therapeutic strategies targeting the cGAS-STING-macrophage axis for renal fibrosis and chronic kidne…
This research reveals a new way to stop kidney damage before it leads to failure.